| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/22/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/21/2023 |
8-K
| Quarterly results |
| 08/21/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 1.5% stake in Ocugen, Inc. |
| 06/16/2023 |
4
| Zhang Junge (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Bought 200,278 shares
@ $0.4993, valued at
$100k
|
|
| 06/09/2023 |
4
| Castillo Kirsten (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
4
| Fernandes Prabhavathi (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
4
| Kompella Uday (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
4
| WHITTINGTON MARNA C (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
4
| Zhang Junge (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 06/09/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/25/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/23/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/11/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/08/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Quarterly results |
| 05/05/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/20/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/10/2023 |
3
| Vu Quan Anh (CFO/CBO) has filed a Form 3 on Ocugen, Inc. |
| 03/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|